Ignite Creation Date:
2024-05-06 @ 6:45 PM
Last Modification Date:
2024-10-26 @ 2:54 PM
Study NCT ID:
NCT05779631
Status:
RECRUITING
Last Update Posted:
2024-01-08
First Post:
2023-03-09
Brief Title:
Multi-parametric MRI in Patients Suspected for Muscle Invasive Bladder Cancer a New Local Staging Paradigm
Sponsor:
Radboud University Medical Center
Organization:
Radboud University Medical Center
Study Overview
Official Title:
Multi-parametric MRI in Patients Suspected for Muscle Invasive Bladder Cancer a New Local Staging Paradigm BladParadigm
Status:
RECRUITING
Status Verified Date:
2024-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
BladParadigm
Brief Summary:
A two-arm multicenter randomised controlled trial comparing progression free survival time to definitive treatment and cost-effectiveness of the standard of care TURBT and mpMRI followed by same-day cystoscopic bladder biopsy for diagnosis of patients with suspicion of muscle-invasive bladder cancer
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None